|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGlynn KA, Petrick JL and El-Serag HB:
Epidemiology of hepatocellular carcinoma. Hepatology. 73 (Suppl
1):S4–S13. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Kelley RK, Villanueva A, Singal
AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and
Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morishita A, Oura K, Tadokoro T, Fujita K,
Tani J and Masaki T: MicroRNAs in the pathogenesis of
hepatocellular carcinoma: A review. Cancers (Basel). 13:5142021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hobert O: Gene regulation by transcription
factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohen A, Burgos-Aceves MA and Smith Y:
Estrogen repression of microRNA as a potential cause of cancer.
Biomed Pharmacother. 78:234–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong LI, Zheng Y, Gao L and Luo X: lncRNA
NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's
disease by impairing miR-374c-5p. Acta Biochim Biophys Sin
(Shanghai). 53:870–882. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu H, Zhang Y, Chen Y, Chen J and Chen P:
CSN1 facilitates proliferation and migration of hepatocellular
carcinoma cells by upregulating cyclin A2 expression. Mol Med Rep.
23:462021.PubMed/NCBI
|
|
12
|
Mullard A: Addressing cancer's grand
challenges. Nat Rev Drug Discov. 19:825–826. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Puik JR, Meijer LL, Le Large TY, Prado MM,
Frampton AE, Kazemier G and Giovannetti E: miRNA profiling for
diagnosis, prognosis and stratification of cancer treatment in
cholangiocarcinoma. Pharmacogenomics. 18:1343–1358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang M, Matyunina LV, Walker LD, Chen W,
Xiao H, Benigno BB, Wu R and McDonald JF: Evidence for the
importance of post-transcriptional regulatory changes in ovarian
cancer progression and the contribution of miRNAs. Sci Rep.
7:81712017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perron MP and Provost P: Protein
interactions and complexes in human microRNA biogenesis and
function. Front Biosci. 13:2537–2547. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He C, Li Z, Chen P, Huang H, Hurst LD and
Chen J: Young intragenic miRNAs are less coexpressed with host
genes than old ones: Implications of miRNA-host gene coevolution.
Nucleic Acids Res. 40:4002–4012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao X, Qiao Y, Han D, Zhang Y and Ma N:
Enemy or partner: Relationship between intronic micrornas and their
host genes. IUBMB Life. 64:835–840. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hinske LC, Galante PA, Kuo WP and
Ohno-Machado L: A potential role for intragenic miRNAs on their
hosts' interactome. BMC Genomics. 11:5332010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Y, Huang H, Li M, Zhang X, Liu Y and
Wang Y: MicroRNA-374c-5p regulates the invasion and migration of
cervical cancer by acting on the Foxc1/snail pathway. Biomed
Pharmacother. 94:1038–1047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao S, Tian W, Chen Y, Wang L, Jiang Y,
Gao B and Luo D: MicroRNA-374c-5p inhibits the development of
breast cancer through TATA-box binding protein associated factor
7-mediated transcriptional regulation of DEP domain containing 1. J
Cell Biochem. 120:15360–15368. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yue Y, Deng P, Xiao H, Tan M, Wang H, Tian
L, Xie J, Chen M, Luo Y, Wang L, et al: N6-methyladenosine-mediated
downregulation of miR-374c-5p promotes cadmium-induced cell
proliferation and metastasis by targeting GRM3 in breast cancer
cells. Ecotoxicol Environ Saf. 229:1130852022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jayachandran A, Dhungel B and Steel JC:
Epithelial-to-mesenchymal plasticity of cancer stem cells:
Therapeutic targets in hepatocellular carcinoma. J Hematol Oncol.
9:742016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Georgakopoulos-Soares I, Chartoumpekis DV,
Kyriazopoulou V and Zaravinos A: EMT factors and metabolic pathways
in cancer. Front Oncol. 10:4992020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo XC, Li L, Gao ZH, Zhou HW, Li J and
Wang QQ: The long non-coding RNA PTTG3P promotes growth and
metastasis of cervical cancer through PTTG1. Aging (Albany NY).
11:1333–1341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Horning AM, Wang Y, Lin CK, Louie AD,
Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, et al:
Single-Cell RNA-seq reveals a subpopulation of prostate cancer
cells with enhanced cell-cycle-related transcription and attenuated
androgen response. Cancer Res. 78:853–864. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu M, Li G, Wang P, Li X, Lai F, Luo R,
Liu B and Lin J: aarF domain containing kinase 5 gene promotes
invasion and migration of lung cancer cells through
ADCK5-SOX9-PTTG1 pathway. Exp Cell Res. 392:1120022020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Parte S, Virant-Klun I, Patankar M, Batra
SK, Straughn A and Kakar SS: PTTG1: A unique regulator of
stem/cancer stem cells in the ovary and ovarian cancer. Stem Cell
Rev Rep. 15:866–879. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren Q and Jin B: The clinical value and
biological function of PTTG1 in colorectal cancer. Biomed
Pharmacother. 89:108–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng C, Zou Y, Hong W, Bao C and Jia X:
Estrogen-regulated PTTG1 promotes breast cancer progression by
regulating cyclin kinase expression. Mol Med. 26:332020. View Article : Google Scholar : PubMed/NCBI
|
